Blocknomi
TLDR HCW Biologics delivered Q1 2026 revenue of $6.54M, compared to only $5,065 in the same quarter last year, primarily from a $6.5M licensing agreement with Beijing Trimmune. The biotech…
Related articles
-
Top 3 Crypto Presales 2026: Whale Wallets Buy 270,000 BTC in 30 Days While Pepeto Targets 100x Before Listing
Blocknomi Published 05.05.2026 04:30
-
After the $16.5 billion in exploits, DeFi is now being forced toward the controls it once resisted
CryptoSlate Published 10.05.2026 19:00
-
AI Crypto Use Cases to Watch in 2026
Crypto Daily Published 14.05.2026 09:01
-
DTCC to use Chainlink to power 24/7 collateral management network
Cointelegraph Published 12.05.2026 18:45
-
India Jewelry Stocks Lose 12% as Modi Targets $72 Billion Gold Import Bill
BeInCrypto Published 11.05.2026 11:42
-
MegaETH Initiates Token Repurchase Program Powered by USDm Stablecoin Yield
Blocknomi Published 08.05.2026 15:59
-
Bitcoin (BTC) Holds $80K Support as Traders Anticipate Next Rally Signal
Blocknomi Published 11.05.2026 06:16
-
Chainlink Lands DTCC Deal to Automate Collateral Workflows Across Global Blockchains
Bitcoin.com Published 12.05.2026 14:30